Dust Mite Allergy News and Research

RSS
Mite-proof covers may reduce severity of asthma exacerbations in allergic children

Mite-proof covers may reduce severity of asthma exacerbations in allergic children

Study provides specific information about characteristics of dust mite allergens

Study provides specific information about characteristics of dust mite allergens

Study finds age-dependent differences in expression of allergy to dust mites

Study finds age-dependent differences in expression of allergy to dust mites

Researchers one step closer to developing asthma vaccine

Researchers one step closer to developing asthma vaccine

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

Circassia: House dust mite allergy treatment meets primary endpoint in phase II clinical study

Circassia: House dust mite allergy treatment meets primary endpoint in phase II clinical study

AstraZeneca enters agreement with Pfizer for OTC NEXIUM

AstraZeneca enters agreement with Pfizer for OTC NEXIUM

HAL Allergy initiates PURETHAL Mites PHASE II study

HAL Allergy initiates PURETHAL Mites PHASE II study

Researchers to develop house dust mite allergy vaccine that can cure asthma

Researchers to develop house dust mite allergy vaccine that can cure asthma

Circassia announces positive result from phase II T-cell vaccine study for house dust mite allergy

Circassia announces positive result from phase II T-cell vaccine study for house dust mite allergy

Circassia announces advancement in T-cell allergy vaccines development

Circassia announces advancement in T-cell allergy vaccines development

Ragweed allergy season more miserable for people with dog, cat or dust mite allergies

Ragweed allergy season more miserable for people with dog, cat or dust mite allergies

Encouraging results from Circassia's ToleroMune ragweed allergy T-cell vaccine phase II clinical trial

Encouraging results from Circassia's ToleroMune ragweed allergy T-cell vaccine phase II clinical trial

Circassia commences Phase II trials of its T-cell vaccines against house dust mite and cat allergies

Circassia commences Phase II trials of its T-cell vaccines against house dust mite and cat allergies